[Mucosal complication of XXXX ].

@entity1 @entity14219 @entity417 @entity101 @entity232 @entity177 @entity4536 @entity17566 @entity1011 @entity72384 @entity3137
A 74-year-old @entity1 from the rural area of Caicedonia, Valle del Cauca Province, was diagnosed with uncontrolled @entity101 , stage IV @entity177 and severe @entity417 . Fifteen years earlier, while living in Guaviare Province, he was diagnosed with @entity232 -with lesions located on the right upper and lower eyelids, left auricle and limbs. At that time, he received an incomplete treatment with antimonials. The @entity1 had experienced 8 years of progressive @entity3137 located in the upper lip, nasal mucosa and right upper and lower eyelids (figure 1). A histopathological diagnosis of @entity232 was made and confirmed by polymerase chain reaction (figure 2). Treatment with antimonials (Glucantime) was contraindicated due to the @entity1 's comorbidities. Inpatient supervised treatment with @entity14219 ( @entity72384 50 mg capsules) was initiated according to the national guidelines of 1.8 mg/kg/day for 28 days. Clinical follow up and routine laboratory tests ( @entity1011 , BUN, liver function tests and complete blood counts) were done during and after treatment; no complications were reported. Medical follow up was continued until the Internal medicine, ophthalmology, and plastic surgery consultations were provided for subsequent management of the pathology. @entity17566 is a serious preventable complication of @entity4536 . This case illustrated a failure in opportune diagnosis and treatment of this disease as a consequence of an inadequate @entity232 control program. The case indicated the effectiveness of @entity14219 as a therapeutic option in @entity1 for whom antimonial treatment is contraindicated.
